로딩 중…
지수 로딩 중…
Akebia Therapeutics, Inc.
AKBA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.07+4.90%
2026-06-18
Price Chart
Akebia Therapeutics, Inc.-69.94%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $287M |
| Revenue | $232M |
| Net Income | $-21M |
| Total Assets | $363M |
| Net Assets | $27M |
| Value | |
| P/B | 10.49x |
| P/S | 1.24x |
| EV/EBITDA | 43.28x |
| FCF Yield | 20.88% |
| Profitability | |
| ROE | -74.93% |
| ROA | -5.66% |
| Op. Margin | 2.28% |
| Revenue Growth | -6.61% |
| Earnings Growth | -248.13% |
| Financial Health | |
| Debt Ratio | 1224.27% |
| Total Debt | $12M |
| FCF | $60M |
| Cash | $163M |
| Current Ratio | 1.40x |
| Net Debt/EBITDA | -47.47x |
| Performance | |
| 1Y Return | -69.94% |
| 1M Return | 19.54% |
| From 52W High | -73.77% |
| 1Y MDD | -78.23% |
| Trading | |
| Volume | 15,076,579 shares |
| Trading Value | $16M |
| Per Share | |
| EPS | $-0.02 |
| BPS | $0.12 |